Cargando…

Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes

Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndrome. To date, NAFLD is the most frequent chronic liver disease seen day by day in clinical practice across most high-income countries, affecting nearly 25–30% of adults in the general population and u...

Descripción completa

Detalles Bibliográficos
Autores principales: Mantovani, Alessandro, Dalbeni, Andrea, Beatrice, Giorgia, Cappelli, Davide, Gomez-Peralta, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878156/
https://www.ncbi.nlm.nih.gov/pubmed/35207239
http://dx.doi.org/10.3390/jcm11040968
_version_ 1784658595165503488
author Mantovani, Alessandro
Dalbeni, Andrea
Beatrice, Giorgia
Cappelli, Davide
Gomez-Peralta, Fernando
author_facet Mantovani, Alessandro
Dalbeni, Andrea
Beatrice, Giorgia
Cappelli, Davide
Gomez-Peralta, Fernando
author_sort Mantovani, Alessandro
collection PubMed
description Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndrome. To date, NAFLD is the most frequent chronic liver disease seen day by day in clinical practice across most high-income countries, affecting nearly 25–30% of adults in the general population and up to 70% of patients with T2DM. Over the last few decades, it clearly emerged that NAFLD is a “multisystemic disease” and that the leading cause of death among patients with NAFLD is cardiovascular disease (CVD). Indeed, several observational studies and some meta-analyses have documented that NAFLD, especially its advanced forms, is strongly associated with fatal and non-fatal cardiovascular events, as well as with specific cardiac complications, including sub-clinical myocardial alteration and dysfunction, heart valve diseases and cardiac arrhythmias. Importantly, across various studies, these associations remained significant after adjustment for established cardiovascular risk factors and other confounders. Additionally, several observational studies and some meta-analyses have also reported that NAFLD is independently associated with specific microvascular conditions, such as chronic kidney disease and distal or autonomic neuropathy. Conversely, data regarding a potential association between NAFLD and retinopathy are scarce and often conflicting. This narrative review will describe the current evidence about the association between NAFLD and the risk of macro- and microvascular manifestations of CVD, especially in patients with T2DM. We will also briefly discuss the biological mechanisms underpinning the association between NAFLD and its advanced forms and macro- and microvascular CVD.
format Online
Article
Text
id pubmed-8878156
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88781562022-02-26 Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes Mantovani, Alessandro Dalbeni, Andrea Beatrice, Giorgia Cappelli, Davide Gomez-Peralta, Fernando J Clin Med Review Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndrome. To date, NAFLD is the most frequent chronic liver disease seen day by day in clinical practice across most high-income countries, affecting nearly 25–30% of adults in the general population and up to 70% of patients with T2DM. Over the last few decades, it clearly emerged that NAFLD is a “multisystemic disease” and that the leading cause of death among patients with NAFLD is cardiovascular disease (CVD). Indeed, several observational studies and some meta-analyses have documented that NAFLD, especially its advanced forms, is strongly associated with fatal and non-fatal cardiovascular events, as well as with specific cardiac complications, including sub-clinical myocardial alteration and dysfunction, heart valve diseases and cardiac arrhythmias. Importantly, across various studies, these associations remained significant after adjustment for established cardiovascular risk factors and other confounders. Additionally, several observational studies and some meta-analyses have also reported that NAFLD is independently associated with specific microvascular conditions, such as chronic kidney disease and distal or autonomic neuropathy. Conversely, data regarding a potential association between NAFLD and retinopathy are scarce and often conflicting. This narrative review will describe the current evidence about the association between NAFLD and the risk of macro- and microvascular manifestations of CVD, especially in patients with T2DM. We will also briefly discuss the biological mechanisms underpinning the association between NAFLD and its advanced forms and macro- and microvascular CVD. MDPI 2022-02-12 /pmc/articles/PMC8878156/ /pubmed/35207239 http://dx.doi.org/10.3390/jcm11040968 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mantovani, Alessandro
Dalbeni, Andrea
Beatrice, Giorgia
Cappelli, Davide
Gomez-Peralta, Fernando
Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
title Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
title_full Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
title_fullStr Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
title_full_unstemmed Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
title_short Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
title_sort non-alcoholic fatty liver disease and risk of macro- and microvascular complications in patients with type 2 diabetes
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878156/
https://www.ncbi.nlm.nih.gov/pubmed/35207239
http://dx.doi.org/10.3390/jcm11040968
work_keys_str_mv AT mantovanialessandro nonalcoholicfattyliverdiseaseandriskofmacroandmicrovascularcomplicationsinpatientswithtype2diabetes
AT dalbeniandrea nonalcoholicfattyliverdiseaseandriskofmacroandmicrovascularcomplicationsinpatientswithtype2diabetes
AT beatricegiorgia nonalcoholicfattyliverdiseaseandriskofmacroandmicrovascularcomplicationsinpatientswithtype2diabetes
AT cappellidavide nonalcoholicfattyliverdiseaseandriskofmacroandmicrovascularcomplicationsinpatientswithtype2diabetes
AT gomezperaltafernando nonalcoholicfattyliverdiseaseandriskofmacroandmicrovascularcomplicationsinpatientswithtype2diabetes